Michael Sneddon

CEO of JSK Therapeutics

Role
Chief Executive Officer at Jsk Therapeutics, Inc
Location
Provo, UT, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

Experience

  1. Chief Executive Officer

    Jsk Therapeutics, Inc

    Aug 2022 — Present · Salt Lake City, UT, US

    JSK Therapeutics offers a new drug class - a novel cytotoxic designed to deliver targeted and sustained anti cancer effects. Today\'s chemotherapy portfolio is highly toxic and requires extensive supportive care to manage. JSK delivers nitric oxide to kill cancer cells. It has the potential to combat both blood and tumor cancers, delivering the nitric oxide directly to malignant cancer cells.Before being appointed to serve as the CEO, successfully led an investor group, including two institutional investors, to complete a fund raising for JSK Therapeutics to complete its prospective phase 1 clinical trial at Huntsman Cancer Institute. Active in endurance sports, completed the 200+ mile LoToJa bicycle race (Logan Utah to Jackson, Wyoming) three years in a row, rode recently as a member of the Huntsman Heroes Bicycle Team and completed several half and full IronMan triathlons.

Education

  • University of Nebraska-Lincoln

    B.S., Engineering

    1976 — 1981

  • BYU Law School

    J.D./MBA

    1982 — 1986

Skills

  • German
  • Localization
  • Translation Memory
  • Foreign Languages
  • Proofreading
  • Technical Translation
  • Internationalization
  • Intercultural Communication
  • Language Technology
  • Trados
  • Machine Translation
  • Translation
  • Website Localization
  • Cross-Functional Team Leadership
  • Quality Assurance
  • Globalization
  • Interpreting
  • Localization Testing
  • Cat Tools
  • Manuals
  • Language Services
  • Sdl Trados
  • Linguistics
  • Multilingual
  • Sdlx
  • Desktop Publishing
  • International Business
  • International Project Management
  • L10n
  • Leadership
  • Terminology

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Michael Sneddon — Chief Executive Officer at Jsk Therapeutics, Inc in Provo, UT, US | Unifers